首页> 美国卫生研究院文献>ACS AuthorChoice >Synthesis of Apolipoprotein B Lipoparticles to DeliverHydrophobic/Amphiphilic Materials
【2h】

Synthesis of Apolipoprotein B Lipoparticles to DeliverHydrophobic/Amphiphilic Materials

机译:载脂蛋白B脂质体的合成疏水/两亲材料

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To develop a drug delivery system (DDS), it is critical to address challenging tasks such as the delivery of hydrophobic and amphiphilic compounds, cell uptake, and the metabolic fate of the drug delivery carrier. Low-density lipoprotein (LDL) has been acknowledged as the human serum transporter of natively abundant lipoparticles such as cholesterol, triacylglycerides, and lipids. Apolipoprotein B (apo B) is the only protein contained in LDL, and possesses a binding moiety for the LDL receptor that can be internalized and degraded naturally by the cell. Therefore, synthetic/reconstituting apoB lipoparticle (rABL) could be an excellent delivery carrier for hydrophobic or amphiphilic materials. Here, we synthesized rABL in vitro, using full-length apoB through a five-step solvent exchange method, and addressed its potential as a DDS. Our rABL exhibited good biocompatibility when evaluated with cytotoxicity and cell metabolic response assays, and was stable during storage in phosphate-buffered saline at 4 °C for several months. Furthermore, hydrophobic superparamagnetic iron oxide nanoparticles(SPIONPs) and the anticancer drug M4N (tetra-O-methyl nordihydroguaiareticacid), used as an imaging enhancer and lipophilic drug model, respectively,were incorporated into the rABL, leading to the formation of SPIONPs-and M4N- containing rABL (SPIO@rABL and M4N@rABL, respectively). Fouriertransform infrared spectroscopy suggested that rABL has a similarcomposition to that of LDL, and successfully incorporated SPIONPsor M4N. SPIO@rABL presented significant hepatic contrast enhancementin T2-weighted magnetic resonance imagingin BALB/c mice, suggesting its potential application as a medicalimaging contrast agent. M4N@rABL could reduce the viability of thecancer cell line A549. Interestingly, we developed solution-phasehigh-resolution transmission electron microscopy to observe both LDLand SPIO@rABL in the liquid state. In summary, our LDL-based DDS,rABL, has significant potential as a novel DDS for hydrophobic andamphiphilic materials, with good cell internalization properties andmetabolicity.
机译:为了开发药物输送系统(DDS),解决具有挑战性的任务(例如疏水性和两亲性化合物的输送,细胞摄取以及药物输送载体的代谢命运)至关重要。低密度脂蛋白(LDL)已被公认是人类丰富的天然脂质体(例如胆固醇,三酰基甘油酯和脂质)的血清转运蛋白。载脂蛋白B(载脂蛋白B)是LDL中唯一的蛋白,并且具有LDL受体的结合部分,该结合部分可以被细胞内在化和自然降解。因此,合成/重组apoB脂质颗粒(rABL)对于疏水性或两亲性材料而言可能是极好的传递载体。在这里,我们通过全长apoB通过五步溶剂交换方法在体外合成了rABL,并探讨了其作为DDS的潜力。当用细胞毒性和细胞代谢反应分析评估时,我们的rABL表现出良好的生物相容性,并且在4°C的磷酸盐缓冲盐水中存储几个月后保持稳定。此外,疏水性超顺磁性氧化铁纳米粒子(SPIONPs)和抗癌药M4N(四-O-甲基去甲二氢愈创木酚酸),分别用作成像增强剂和亲脂性药物模型,被纳入rABL,导致SPIONP的形成-和含M4N的rABL(分别为SPIO @ rABL和M4N @ rABL)。傅里叶变换红外光谱表明rABL具有相似的组成低密度脂蛋白,并成功纳入SPIONP或M4N。 SPIO @ rABL表现出明显的肝脏对比增强在T2加权磁共振成像中在BALB / c小鼠中的应用,表明其在医学上的潜在应用成像造影剂。 M4N @ rABL可能会降低癌细胞系A549。有趣的是,我们开发了解决方案阶段高分辨率透射电镜观察两种低密度脂蛋白和SPIO @ rABL处于液态。总而言之,我们基于LDL的DDS,rABL作为疏水性DDS的新型DDS具有巨大潜力两亲材料,具有良好的细胞内在性和新陈代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号